Compositions and methods of treatment for severe hypertriglyceridemia
US12036284B2 · kind B2 · utility
0Cited by
9References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 2023 |
| Grant date | Jul 16, 2024 |
| Priority date | — |
| Expiry date | Jun 23, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions, methods and therapeutic regimens of mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugates for the treatment of severe hypertriglyceridemia are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.